Chinese Acute Ischemic Stroke Treatment Outcome Registry (CASTOR)
October 22, 2015 updated by: Yining Huang, Peking University First Hospital
This is a multi-center registry study.
The investigators will include 10,000 patients with confirmed acute ischemic stroke in China.
The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Stroke is a common disease in China.
Compared to western countries, there are many treatment regimens used in clinical practice in China.
But their treatment effects are not well validated.
The aim of the study is to survey current treatment situation in China and compare the effectiveness and safety between different intervention regimens.
Study Type
Observational
Enrollment (Anticipated)
10000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Beijing, China, 100034
- Recruiting
- Peking University First Hospital
-
Contact:
- Yining Huang, MD
- Phone Number: +86(10)83572857
- Email: ynhuang@sina.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
acute ischemic stroke patients
Description
Inclusion Criteria:
- age ≥18 yesrs
- confirmed diagnosis of an ischemic stroke
- admission within 1 week after onset of stroke or within treatment time window for patients of thrombolysis treatment
- signed informed consent
Exclusion Criteria:
- with intracerebral hemorrhage
- with severe morbid (estimated survival duration less than 3 months)
- could not provide follow-up information
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
treatment following current guideline
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
death or severe disability
Time Frame: 90 days
|
90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Yining Huang, MD, Peking University First Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Anticipated)
March 1, 2017
Study Completion (Anticipated)
March 1, 2017
Study Registration Dates
First Submitted
June 10, 2015
First Submitted That Met QC Criteria
June 11, 2015
First Posted (Estimate)
June 12, 2015
Study Record Updates
Last Update Posted (Estimate)
October 23, 2015
Last Update Submitted That Met QC Criteria
October 22, 2015
Last Verified
October 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Neurology-stroke
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.